Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent Lymphoma
Clinical trial NCT00954005 · TERMINATED
Trial details
- NCT number
- NCT00954005
- Sponsor
- German Low Grade Lymphoma Study Group
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2011-06-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.